Infectious diseases are disorders caused by organisms — such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful. But under certain conditions, some organisms may cause disease
This report contains market size and forecasts of Infectious Disease Diagnostic Testing Kit in global, including the following market information:
Global Infectious Disease Diagnostic Testing Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Disease Diagnostic Testing Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Disease Diagnostic Testing Kit companies in 2021 (%)
The global Infectious Disease Diagnostic Testing Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bacteria Caused Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Diagnostic Testing Kit include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Diagnostic Testing Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Diagnostic Testing Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, by Type, 2021 (%)
Bacteria Caused Disease
Fungi Caused Disease
Parasites Caused Disease
Influenza
HIV
Ebola
COVID-19
Other Virus Caused Disease
Global Infectious Disease Diagnostic Testing Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, by Application, 2021 (%)
Hospitals
Scientific Research
Global Infectious Disease Diagnostic Testing Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease Diagnostic Testing Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Diagnostic Testing Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Disease Diagnostic Testing Kit revenues share in global market, 2021 (%)
Key companies Infectious Disease Diagnostic Testing Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Disease Diagnostic Testing Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE